CompletedPhase 4

Comparing Doses of Intrathecal Dexmedetomidine

Pakistan60 participantsStarted 2025-10-22

Plain-language summary

To compare the duration of sensory and motor blockade produced by two different intrathecal doses of dexmedetomidine (5 µg and 10 µg) when added to hyperbaric bupivacaine in patients undergoing elective cesarean section

Who can participate

Age range20 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Parturients aged 20-40 years * ASA physical status II * Scheduled for elective cesarean section * Ability to provide informed written consent Exclusion Criteria: * ASA physical status III or higher * Emergency cesarean section * Previous labor analgesia * History of cardiovascular, neurological, or systemic disease * Contraindications to spinal anesthesia * Surgery duration exceeding 60 minutes

What they're measuring

Duration of sensory blockade

Timeframe: 6 hrs

Duration of motor blockade

Timeframe: 6 hrs

Trial details

NCT IDNCT07395271

SponsorBahria International Hospital

Sponsor typeUNKNOWN

Study typeINTERVENTIONAL

Primary completion2026-01-21

View on ClinicalTrials.gov More Dexmedetomidine trials